Stock comparison
DEXCOM INC is 12.1x more valuable than AtriCure, Inc. by market capitalization ($32.54 B vs $2.70 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
DEXCOM INC is 12.1x more valuable than AtriCure, Inc. by market capitalization ($32.54 B vs $2.70 B).
Market value leader
DXCM
DEXCOM INC is 12.1x more valuable than AtriCure, Inc. by market capitalization ($32.54 B vs $2.70 B).
Revenue leader
DXCM
ATRC: $534.53M vs DXCM: $4.66B.
Profit leader
DXCM
ATRC: -$11.45M vs DXCM: $836.30M.
Margin leader
DXCM
ATRC: -2.1% vs DXCM: 17.9% net margin.
| Metric | ATRC | DXCM |
|---|---|---|
| Market cap | $2.70 B | $32.54 B |
| US-listed rank | #1909 | #441 |
| Revenue (latest FY) | $534.53M | $4.66B |
| Net income (latest FY) | -$11.45M | $836.30M |
| Net margin | -2.1% | 17.9% |
| P/E (trailing FY) | - | 38.9x |
| SEC filings | 1,528 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
DEXCOM INC is 12.1x more valuable than AtriCure, Inc. by market capitalization ($32.54 B vs $2.70 B).
In their latest fiscal years, AtriCure, Inc. reported $534.53M in revenue while DEXCOM INC reported $4.66B.
Full pages: AtriCure, Inc. and DEXCOM INC, or browse the full rankings.